Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : anika research(anik) -- Ignore unavailable to you. Want to Upgrade?

To: Sylvester who wrote (118)	5/7/1998 7:50:00 AM
From: James Baker	Read Replies (1) \| Respond to of 328

I don't think that it means anything. This stock is really waiting for FDA approval for US marketing of OrthoVisc and until that happens everything else is just speculation. The FDA said that no panel review will be required so this should speed the approval process. I believe the NDA was accepted in Feb so it would not be surprising to have approval in the next 2-3 months. All guesses. I have owned BIOX and I think investing now in ANIK make sense. The market seems large enough on a worldwide basis to support both companies doing very similar R&D. Jim